{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:49:05Z","timestamp":1783784945767,"version":"3.55.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Hematopoietic stem cell transplantation (HSCT) has been newly identified as an etiology underlying acquired lipodystrophy (ALD). We report about two children with leukemia who underwent HSCT and later manifested aberrant fat distributions consistent with acquired partial lipodystrophy (APL). Both patients manifested graft-versus-host disease (GVHD), suggesting that GVHD may trigger lipodystrophy. The patients exhibited diabetic blood glucose patterns in the oral glucose tolerance test (OGTT) with high homeostasis model assessment ratios (HOMA-Rs), hypertriglyceridemia, fatty liver, and decreased serum leptin and adiponectin levels. Both patients were diagnosed with APL with metabolic disease. A review of the data of patients with ALD after HSCT revealed common clinical features, including aberrant fat distribution, impaired glucose tolerance (IGT) or diabetes and dyslipidemia. Based on previous reports and our two cases, we speculate that GVHD in the adipose tissue supports the development of ALD after HSCT. In conclusion, children may develop APL after HSCT. Therefore, evaluations of fat distribution and metabolic disease may be important during the long-term follow-up of these patients.<\/jats:p>","DOI":"10.1515\/jpem-2018-0356","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T09:02:41Z","timestamp":1557478961000},"page":"537-541","source":"Crossref","is-referenced-by-count":15,"title":["Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature"],"prefix":"10.1515","volume":"32","author":[{"given":"Mayumi","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2662-4121","authenticated-orcid":false,"given":"Junichiro","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref61","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study","volume":"169","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/DAD.0000000000000721","article-title":"Lipophagic panniculitis of childhood: a case report and comprehensive review of the literature","volume":"39","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/DAD.0000000000000721","article-title":"Lipophagic panniculitis of childhood: a case report and comprehensive review of the literature","volume":"39","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"ref21","first-page":"1","article-title":"Smoothed percentage body fat percentiles for U.S. children and adolescents, 1999\u20132004","volume":"43","year":"2011","journal-title":"Natl Health Stat Report"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/jpem-2016-0306","article-title":"Evaluation of endocrine and metabolic dysfunctions after hematopoietic stem cell transplantation in children: a study from Turkey","volume":"30","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.2006.01855.x","article-title":"Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study","volume":"169","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3389\/fimmu.2018.02142","article-title":"Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"ref181","first-page":"1","article-title":"Smoothed percentage body fat percentiles for U.S. children and adolescents, 1999\u20132004","volume":"43","year":"2011","journal-title":"Natl Health Stat Report"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40618-017-0731-x","article-title":"Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list","volume":"40","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-018-1589-1","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy","volume":"60","year":"2018","journal-title":"Endocrine"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/jpem-2016-0306","article-title":"Evaluation of endocrine and metabolic dysfunctions after hematopoietic stem cell transplantation in children: a study from Turkey","volume":"30","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","year":"2004","journal-title":"Medicine"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","year":"2001","journal-title":"Nat Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3389\/fimmu.2018.02142","article-title":"Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","year":"2004","journal-title":"Medicine"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","year":"2003","journal-title":"Medicine"},{"key":"ref231","article-title":"Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease","volume":"64","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1432-2277.1997.tb00685.x","article-title":"Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants","volume":"10","year":"1997","journal-title":"Transpl Int"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40618-017-0731-x","article-title":"Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list","volume":"40","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.2006.01855.x","article-title":"Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1432-2277.1997.tb00685.x","article-title":"Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants","volume":"10","year":"1997","journal-title":"Transpl Int"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2353\/ajpath.2009.080505","article-title":"Adipose tissue sensitivity to radiation exposure","volume":"174","year":"2009","journal-title":"Am J Pathol"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1297\/cpe.22.53","article-title":"Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy","volume":"22","year":"2013","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2353\/ajpath.2009.080505","article-title":"Adipose tissue sensitivity to radiation exposure","volume":"174","year":"2009","journal-title":"Am J Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1297\/cpe.22.53","article-title":"Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy","volume":"22","year":"2013","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref71","article-title":"Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease","volume":"64","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","year":"2001","journal-title":"Nat Med"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-018-1589-1","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy","volume":"60","year":"2018","journal-title":"Endocrine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","year":"2003","journal-title":"Medicine"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2019.32.issue-5\/jpem-2018-0356\/jpem-2018-0356.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2018-0356\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:44:39Z","timestamp":1619055879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2018-0356\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":32,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2018-0356","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,27]]}}}